Judith Michels

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine et al. · Nature · 2017 · 562 citations

Medicine, Genetics, Oncology +16

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

Olivier Mir, Romain Coriat, Benoı̂t Blanchet et al. · PLoS ONE · 2012 · 298 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

Soizick Mesnage, Aurélie Auguste, Catherine Genestie et al. · Annals of Oncology · 2016 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Cisplatin Resistance Associated with PARP Hyperactivation

Judith Michels, Ilio Vitale, Lorenzo Galluzzi et al. · Cancer Research · 2013 · 170 citations

Medicine, Oncology, Pharmacology +17

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla et al. · Cell Reports · 2012 · 134 citations · Full text

Medicine, Oncology, Pharmacology +15